IBDEI0R8 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13402,1,5,0)
 ;;=5^Ebola Virus
 ;;^UTILITY(U,$J,358.3,13402,2)
 ;;=^295629
 ;;^UTILITY(U,$J,358.3,13403,0)
 ;;=070.51^^81^842^4
 ;;^UTILITY(U,$J,358.3,13403,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13403,1,4,0)
 ;;=4^070.51
 ;;^UTILITY(U,$J,358.3,13403,1,5,0)
 ;;=5^Hepatitis C w/o Coma
 ;;^UTILITY(U,$J,358.3,13403,2)
 ;;=^331778
 ;;^UTILITY(U,$J,358.3,13404,0)
 ;;=042.^^81^842^1
 ;;^UTILITY(U,$J,358.3,13404,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13404,1,4,0)
 ;;=4^042.
 ;;^UTILITY(U,$J,358.3,13404,1,5,0)
 ;;=5^HIV Disease
 ;;^UTILITY(U,$J,358.3,13404,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,13405,0)
 ;;=070.54^^81^842^6
 ;;^UTILITY(U,$J,358.3,13405,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13405,1,4,0)
 ;;=4^070.54
 ;;^UTILITY(U,$J,358.3,13405,1,5,0)
 ;;=5^Hepatitis C,Chronic
 ;;^UTILITY(U,$J,358.3,13405,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,13406,0)
 ;;=070.70^^81^842^5
 ;;^UTILITY(U,$J,358.3,13406,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13406,1,4,0)
 ;;=4^070.70
 ;;^UTILITY(U,$J,358.3,13406,1,5,0)
 ;;=5^Hepatitis C w/o Coma,Unspec
 ;;^UTILITY(U,$J,358.3,13406,2)
 ;;=^331436
 ;;^UTILITY(U,$J,358.3,13407,0)
 ;;=599.0^^81^842^16
 ;;^UTILITY(U,$J,358.3,13407,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13407,1,4,0)
 ;;=4^599.0
 ;;^UTILITY(U,$J,358.3,13407,1,5,0)
 ;;=5^UTI NOS
 ;;^UTILITY(U,$J,358.3,13407,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,13408,0)
 ;;=070.32^^81^842^2
 ;;^UTILITY(U,$J,358.3,13408,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13408,1,4,0)
 ;;=4^070.32
 ;;^UTILITY(U,$J,358.3,13408,1,5,0)
 ;;=5^Hepatitis B w/o Coma w/o Delta,Chronic
 ;;^UTILITY(U,$J,358.3,13408,2)
 ;;=^303249
 ;;^UTILITY(U,$J,358.3,13409,0)
 ;;=795.79^^81^842^14
 ;;^UTILITY(U,$J,358.3,13409,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13409,1,4,0)
 ;;=4^795.79
 ;;^UTILITY(U,$J,358.3,13409,1,5,0)
 ;;=5^Nonspec Immune Finding,Oth/Unspec
 ;;^UTILITY(U,$J,358.3,13409,2)
 ;;=^303352
 ;;^UTILITY(U,$J,358.3,13410,0)
 ;;=031.9^^81^842^13
 ;;^UTILITY(U,$J,358.3,13410,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13410,1,4,0)
 ;;=4^031.9
 ;;^UTILITY(U,$J,358.3,13410,1,5,0)
 ;;=5^Mycobacterial Disease NOS
 ;;^UTILITY(U,$J,358.3,13410,2)
 ;;=^123817
 ;;^UTILITY(U,$J,358.3,13411,0)
 ;;=041.12^^81^842^11
 ;;^UTILITY(U,$J,358.3,13411,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13411,1,4,0)
 ;;=4^041.12
 ;;^UTILITY(U,$J,358.3,13411,1,5,0)
 ;;=5^MRSA Elsewhere NOS
 ;;^UTILITY(U,$J,358.3,13411,2)
 ;;=^336700
 ;;^UTILITY(U,$J,358.3,13412,0)
 ;;=070.30^^81^842^3
 ;;^UTILITY(U,$J,358.3,13412,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13412,1,4,0)
 ;;=4^070.30
 ;;^UTILITY(U,$J,358.3,13412,1,5,0)
 ;;=5^Hepatitis B w/o Coma w/o Delta,Viral
 ;;^UTILITY(U,$J,358.3,13412,2)
 ;;=^266626
 ;;^UTILITY(U,$J,358.3,13413,0)
 ;;=088.81^^81^842^10
 ;;^UTILITY(U,$J,358.3,13413,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13413,1,4,0)
 ;;=4^088.81
 ;;^UTILITY(U,$J,358.3,13413,1,5,0)
 ;;=5^Lyme Disease
 ;;^UTILITY(U,$J,358.3,13413,2)
 ;;=^72315
 ;;^UTILITY(U,$J,358.3,13414,0)
 ;;=136.9^^81^842^9
 ;;^UTILITY(U,$J,358.3,13414,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13414,1,4,0)
 ;;=4^136.9
 ;;^UTILITY(U,$J,358.3,13414,1,5,0)
 ;;=5^Infect/Parasite Disease NOS
 ;;^UTILITY(U,$J,358.3,13414,2)
 ;;=^123934
 ;;^UTILITY(U,$J,358.3,13415,0)
 ;;=573.3^^81^842^7
 ;;^UTILITY(U,$J,358.3,13415,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13415,1,4,0)
 ;;=4^573.3
 ;;^UTILITY(U,$J,358.3,13415,1,5,0)
 ;;=5^Hepatitis NOS
 ;;^UTILITY(U,$J,358.3,13415,2)
 ;;=^56268
 ;;^UTILITY(U,$J,358.3,13416,0)
 ;;=038.9^^81^842^15
 ;;^UTILITY(U,$J,358.3,13416,1,0)
 ;;=^358.31IA^5^2
